Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Barton CD, Pizer B, Jones C, Oni L, Pirmohamed M, Hawcutt DB (2018) Identifying cisplatin-induced kidney damage in paediatric oncology patients. Pediatr Nephrol 33(9):1467–1474
2. Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47–61
3. Almanric K, Marceau N, Cantin A, Bertin É (2017) Risk factors for nephrotoxicity associated with cisplatin. Can J Hosp Pharm 70(2):99–106
4. Bodnar L, Wcisle G, Gasowska-Bodnar A, Synowies A, Szarlec-Wcislo K, Szczylik C (2008) Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a randomised phase II study. Eur J Cancer 44:2608–2614
5. US Department of Health and Human Services: Common Terminology Criteria for Adverse Events (CTCAE version) 4.0 (2020). https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-JUNE
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献